Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Yuan-Liang Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China. Hauptthemen laut MEDLINE: NF-kappa B, Anti-Inflammatory Agents, Drug Design, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Nuclear factor κB (NF‐κB) is a key inducible transcription factor that controls a large number of genes involved in inflammatory and immune processes. The entire inflammation‐mediated process uses NF‐κB as a hub, and inflammatory gene transcription and expression can be decreased by blocking the NF‐κB signaling pathway, thereby reducing inflammatory damage. Therefore, the inhibition of this pathway is an important therapeutic target for the treatment of various types of inflammation. Here, we designed and synthesized 27 mollugin derivatives and evaluated the anti‐inflammatory activity against NF‐κB transcription. Most of the compounds exhibited potent anti‐inflammatory activity, and compound 5k was the most potent with 81.77% inhibition after intraperitoneal administration, which was significantly more potent than mollugin (49.72%), ibuprofen (47.51%), and mesalazine (47.24%). Investigation of the mechanism of action indicated that 5k down‐regulated NF‐κB expression, possibly by suppressing LPS‐induced expression of the p65 protein. ADMET prediction analysis indicated that compounds 5h and 5k showed good pharmacokinetic properties. The relationship between the structures of the synthesized compounds and the NF‐κB inhibitory activity was rationalized using molecular docking simulation experiments. Overall, these results provide an initial basis for the development of 5h and 5k as potential anti‐inflammatory agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, Y. L., Li, M. Y., Wang, D. Y., Jin, S. A., Ma, X. Y., Jin, X. J., & Piao, H. R. (2024). Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70024
Vancouver
Gao YL, Li MY, Wang DY, Jin SA, Ma XY, Jin XJ, et al. Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70024
BibTeX
@article{Gao2024,
author = {Gao, Yuan-Liang and Li, Ming-Yue and Wang, Da-Yuan and Jin, Shi-Ang and Ma, Xin-Yu and Jin, Xue-Jun and Piao, Hu-Ri},
title = {Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.70024}
}
EUVIMED